The study found significant intra-group CMT reductions in the DEX-I group, with a higher percentage reduction than the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In support of improving patient care, this activity has ...

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...

The "Diabetic Macular Edema (DME): Epidemiology Forecast to 2034" report has been added to ResearchAndMarkets.com's offering.

The St. Joseph’s Hospital Foundation purchased new retinal imaging technology that enhances early detection and monitoring of conditions like diabetic retinopathy, glaucoma and macular degeneration.

Researchers at Keck Medicine of USC are launching a phase 2b clinical trial examining if stem cells bioengineered to replace failing cells in the retina damaged by macular degeneration could restore ...